Legend Historical Income Statement
LEGN Stock | USD 47.45 0.39 0.83% |
Historical analysis of Legend BiotechCorp income statement accounts such as Total Revenue of 299.4 M can show how well Legend BiotechCorp performed in making a profits. Evaluating Legend BiotechCorp income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Legend BiotechCorp's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Legend BiotechCorp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Legend BiotechCorp is a good buy for the upcoming year.
Legend |
About Legend Income Statement Analysis
Legend BiotechCorp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Legend BiotechCorp shareholders. The income statement also shows Legend investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Legend BiotechCorp Income Statement Chart
Legend BiotechCorp Income Statement is one of the three primary financial statements used for reporting Legend's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Legend BiotechCorp revenue and expense. Legend BiotechCorp Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Legend BiotechCorp's Interest Expense is very stable compared to the past year. As of the 24th of April 2024, Selling General Administrative is likely to grow to about 112.1 M, while Tax Provision is likely to drop about 268.9 K. Add Fundamental
Total Revenue
Total revenue comprises all receipts Legend BiotechCorp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Legend BiotechCorp. It is also known as Legend BiotechCorp overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Legend BiotechCorp's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Legend BiotechCorp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend BiotechCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.At this time, Legend BiotechCorp's Interest Expense is very stable compared to the past year. As of the 24th of April 2024, Selling General Administrative is likely to grow to about 112.1 M, while Tax Provision is likely to drop about 268.9 K.
2021 | 2022 | 2023 | 2024 (projected) | Other Operating Expenses | 462.8M | 575.1M | 727.4M | 365.7M | Total Revenue | 89.8M | 117.0M | 285.1M | 299.4M |
Legend BiotechCorp income statement Correlations
Click cells to compare fundamentals
Legend BiotechCorp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Legend BiotechCorp income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Tax Provision | 2.6M | (4.1M) | 1K | 625K | 283K | 268.9K | |
Interest Expense | 223K | 4.2M | 900K | 10.8M | 21.8M | 22.9M | |
Selling General Administrative | 6.8M | 23.1M | 46.9M | 80.6M | 106.8M | 112.1M | |
Total Revenue | 57.3M | 75.7M | 89.8M | 117.0M | 285.1M | 299.4M | |
Other Operating Expenses | 192.6M | 304.9M | 462.8M | 575.1M | 727.4M | 365.7M | |
Operating Income | (130.9M) | (313.3M) | (393.0M) | (455.8M) | (442.2M) | (420.1M) | |
Ebit | (130.9M) | (313.3M) | (393.0M) | (455.8M) | (442.2M) | (420.1M) | |
Income Before Tax | (130.4M) | (307.6M) | (386.2M) | (445.7M) | (520.1M) | (494.1M) | |
Net Income Applicable To Common Shares | (133.0M) | (303.5M) | (386.2M) | (446.3M) | (401.7M) | (381.6M) | |
Net Income | (133.0M) | (303.5M) | (386.2M) | (446.3M) | (518.3M) | (492.3M) | |
Income Tax Expense | 2.6M | (4.1M) | 1K | 625K | (1.9M) | (1.8M) | |
Net Interest Income | 4.4M | (4.2M) | (900K) | (10.8M) | 21.2M | 22.3M | |
Interest Income | 4.6M | 2.9M | 971K | 8.2M | 42.1M | 44.2M | |
Depreciation And Amortization | 5.3M | 9.9M | 13.9M | 18.4M | 20.5M | 12.8M | |
Selling And Marketing Expenses | 25.6M | 49.6M | 102.5M | 93.4M | 94.2M | 67.2M | |
Gross Profit | 57.3M | (156.5M) | (223.6M) | 51.6M | 120.5M | 126.5M | |
Net Income From Continuing Ops | (133.0M) | (303.5M) | (386.2M) | (446.3M) | (509.3M) | (483.8M) | |
Research Development | 161.9M | 232.2M | 313.3M | 335.6M | 382.2M | 272.4M | |
Ebitda | (125.6M) | (303.4M) | (379.1M) | (437.4M) | (421.8M) | (442.9M) | |
Total Operating Expenses | 192.6M | 304.9M | 462.8M | 509.7M | 562.7M | 384.4M | |
Reconciled Depreciation | 5.3M | 9.9M | 13.9M | 18.4M | 20.3M | 12.7M | |
Total Other Income Expense Net | 501K | 5.7M | 6.8M | 10.1M | (77.9M) | (74.0M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend BiotechCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 1.619 | Quarterly Revenue Growth 1.876 | Return On Assets (0.17) | Return On Equity (0.52) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.